Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -7.79%258.33M | ---- | 260.59%280.15M | ---- | 51.13%-174.44M | ---- | 33.54%-356.95M | ---- | -290.67%-537.06M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -156.63%-50.64M | ---- | -78.32%-19.73M | ---- | -9.15%-11.07M | ---- | 35.90%-10.14M | ---- | 28.59%-15.82M |
| Interest expense - adjustment | ---- | 13.83%309.96M | ---- | 26.05%272.3M | ---- | 5.91%216.02M | ---- | -4.05%203.96M | ---- | -5.21%212.57M |
| Dividend (income)- adjustment | ---- | -10.91%-1.02M | ---- | 22.62%-917K | ---- | 74.85%-1.19M | ---- | -367.92%-4.71M | ---- | 18.00%-1.01M |
| Attributable subsidiary (profit) loss | ---- | 4.37%-309.66M | ---- | -69.74%-323.82M | ---- | 9.00%-190.77M | ---- | -58.35%-209.64M | ---- | 39.94%-132.39M |
| Impairment and provisions: | ---- | 14.72%45.97M | ---- | 1,196.76%40.07M | ---- | -98.23%3.09M | ---- | 1,054.26%174.49M | ---- | -26.14%15.12M |
| -Impairment of property, plant and equipment (reversal) | ---- | 14.72%45.97M | ---- | --40.07M | ---- | ---- | ---- | --122.86M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | -94.02%3.09M | ---- | 241.56%51.63M | ---- | --15.12M |
| Revaluation surplus: | ---- | -47.08%6.83M | ---- | 117.93%12.91M | ---- | -1,225.76%-71.99M | ---- | -119.91%-5.43M | ---- | 152.25%27.27M |
| -Fair value of investment properties (increase) | ---- | 488.13%20.71M | ---- | 105.44%3.52M | ---- | -827.03%-64.7M | ---- | -54.17%8.9M | ---- | 136.91%19.42M |
| -Other fair value changes | ---- | -247.90%-13.88M | ---- | 228.75%9.39M | ---- | 49.12%-7.29M | ---- | -282.58%-14.33M | ---- | 1,712.47%7.85M |
| Asset sale loss (gain): | ---- | 339.42%5.33M | ---- | 85.26%-2.23M | ---- | -1,318.42%-15.09M | ---- | -189.56%-1.06M | ---- | -79.82%1.19M |
| -Loss (gain) from sale of subsidiary company | ---- | --4.35M | ---- | ---- | ---- | ---10.59M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -2.23%2.67M | ---- | 189.10%2.73M | ---- | ---3.07M | ---- | ---- | ---- | -79.82%1.19M |
| -Loss (gain) from selling other assets | ---- | 65.80%-1.7M | ---- | -243.93%-4.96M | ---- | -35.43%-1.44M | ---- | ---1.06M | ---- | ---- |
| Depreciation and amortization: | ---- | -2.44%262.27M | ---- | -3.53%268.84M | ---- | -12.57%278.67M | ---- | -1.21%318.74M | ---- | -5.11%322.64M |
| -Amortization of intangible assets | ---- | -24.48%7.11M | ---- | 20.57%9.42M | ---- | 9.27%7.81M | ---- | 105.14%7.15M | ---- | 15.09%3.49M |
| Exchange Loss (gain) | ---- | -70.53%-23.75M | ---- | -109.61%-13.93M | ---- | 1,578.74%144.91M | ---- | -64.42%8.63M | ---- | 162.08%24.26M |
| Special items | ---- | 12.50%11.87M | ---- | 1,264.42%10.55M | ---- | 549.42%773K | ---- | 91.49%-172K | ---- | -197.30%-2.02M |
| Operating profit before the change of operating capital | ---- | -1.66%515.5M | ---- | 192.98%524.2M | ---- | 52.00%178.92M | ---- | 238.09%117.71M | ---- | -114.51%-85.24M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -40.86%783K | ---- | 154.67%1.32M | ---- | -248.23%-2.42M | ---- | -51.38%1.63M | ---- | 30.42%3.36M |
| Accounts receivable (increase)decrease | ---- | 141.22%10.1M | ---- | 12.73%-24.51M | ---- | -229.67%-28.09M | ---- | -70.53%21.66M | ---- | 621.27%73.5M |
| Accounts payable increase (decrease) | ---- | -202.91%-33.86M | ---- | -0.82%32.9M | ---- | 190.01%33.17M | ---- | 60.59%-36.86M | ---- | -3,257.09%-93.51M |
| Special items for working capital changes | ---- | -29.24%8.65M | ---- | 130.02%12.22M | ---- | -103.87%-40.7M | ---- | -531.94%-19.96M | ---- | 93.53%-3.16M |
| Cash from business operations | -10.66%150.76M | -8.23%501.17M | -10.94%168.74M | 287.64%546.13M | 787.75%189.47M | 67.35%140.89M | -43.05%-27.55M | 180.14%84.19M | ---19.26M | -119.81%-105.06M |
| Hong Kong profits tax paid | ---- | 103.70%5K | ---- | 28.95%-135K | ---- | -41.79%-190K | ---- | 98.32%-134K | ---- | ---7.99M |
| Other taxs | -2.23%-27.12M | -44.99%-50.69M | -86.24%-26.52M | -153.98%-34.96M | -73.35%-14.24M | 50.79%-13.76M | 26.76%-8.22M | 35.42%-27.97M | ---11.22M | 40.44%-43.31M |
| Interest paid - operating | -1.91%-146.68M | -12.17%-305.33M | -8.26%-143.92M | -24.88%-272.21M | -33.17%-132.94M | -8.70%-217.97M | -6.11%-99.83M | 2.75%-200.52M | ---94.08M | 9.22%-206.19M |
| Net cash from operations | -1,252.61%-23.04M | -39.22%145.16M | -104.03%-1.7M | 362.34%238.83M | 131.18%42.28M | 36.97%-91.04M | -8.86%-135.59M | 60.16%-144.43M | 62.75%-124.55M | -257.34%-362.55M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 58.73%37.46M | 174.20%57.16M | 196.23%23.6M | 98.71%20.85M | 103.94%7.97M | -57.41%10.49M | -80.44%3.91M | 65.84%24.63M | 123.12%19.97M | -22.02%14.85M |
| Dividend received - investment | 66.85%51.95M | 41.46%149.14M | 52.03%31.13M | -19.83%105.43M | 505.14%20.48M | 171.78%131.51M | 80.87%3.38M | -10.55%48.39M | -51.06%1.87M | -58.72%54.1M |
| Loan receivable (increase) decrease | -79.00%6.41M | 148.36%24.21M | 297.00%30.53M | -3,174.56%-50.07M | -2,365.79%-15.5M | -103.66%-1.53M | -98.37%684K | 1,709.70%41.79M | 539.77%42.03M | 139.20%2.31M |
| Decrease in deposits (increase) | -277.70%-47.96M | 79.61%-17.09M | 158.23%26.99M | -418.35%-83.83M | -3,009.42%-46.35M | -2.71%26.33M | -88.53%1.59M | -33.64%27.07M | -54.51%13.89M | 324.08%40.79M |
| Sale of fixed assets | 46.36%483K | 114.51%414K | --330K | -97.30%193K | ---- | 49.72%7.15M | ---- | 980.32%4.78M | ---- | 16.93%442K |
| Purchase of fixed assets | 41.28%-29.86M | -57.12%-63.2M | 23.16%-50.86M | -56.45%-40.23M | -7.90%-66.18M | 41.84%-25.71M | -63.96%-61.33M | 52.35%-44.21M | 18.12%-37.41M | 49.32%-92.79M |
| Purchase of intangible assets | ---- | -1.38%-47.9M | ---- | 12.00%-47.25M | ---- | -56.04%-53.69M | ---- | -19.63%-34.41M | ---- | 52.67%-28.76M |
| Sale of subsidiaries | ---- | --673K | ---- | ---- | ---- | -44.88%22.85M | 630.03%22.85M | --41.45M | --3.13M | ---- |
| Recovery of cash from investments | -80.79%2.69M | 192.13%56.19M | 25.46%14.02M | -46.97%19.23M | -63.20%11.17M | 62.39%36.27M | --30.36M | --22.33M | ---- | ---- |
| Cash on investment | ---2.51M | 87.51%-10.22M | ---- | -24.96%-81.85M | ---2.91M | -25.82%-65.5M | ---- | -264.38%-52.06M | ---10.8M | 86.23%-14.29M |
| Other items in the investment business | ---- | ---- | ---- | ---- | -19.74%2.38M | ---- | -14.91%2.96M | ---- | 422.11%3.48M | ---- |
| Net cash from investment operations | -75.36%18.66M | 194.82%149.37M | 185.16%75.74M | -278.66%-157.52M | -2,118.08%-88.94M | 10.54%88.17M | -87.82%4.41M | 441.49%79.76M | 991.19%36.17M | 89.44%-23.36M |
| Net cash before financing | -105.91%-4.38M | 262.23%294.53M | 258.70%74.04M | 2,931.09%81.31M | 64.44%-46.65M | 95.56%-2.87M | -48.44%-131.18M | 83.24%-64.68M | 73.30%-88.38M | -4,312.48%-385.91M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -62.59%356.96M | 70.33%2.52B | 3,898.39%954.1M | 276.91%1.48B | -52.50%23.86M | -34.51%393.27M | 124.24%50.23M | 0.37%600.5M | -249.39%-207.19M | -72.88%598.28M |
| Refund | ---- | -24.70%-1.92B | ---- | -405.42%-1.54B | ---- | 60.02%-304.71M | ---- | -92.77%-762.15M | ---- | 82.98%-395.36M |
| Issuance of bonds | 168.80%375.41M | 134.61%279.22M | --139.66M | --119.02M | ---- | ---- | ---- | -59.10%75.6M | -59.10%75.6M | -16.60%184.85M |
| Dividends paid - financing | 25.88%-51.74M | -5,400.62%-106M | ---69.8M | 3.41%-1.93M | ---- | 62.37%-2M | ---- | 56.50%-5.3M | 39.81%-1.65M | 89.80%-12.19M |
| Issuance expenses and redemption of securities expenses | ---- | ---99.61M | ---99.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -100.34%-2.96M | 125.80%2.2M | 82.12%-1.48M | -38.59%-8.51M | -1,768.55%-8.26M | ---6.14M | ---442K | ---- | ---- | ---- |
| Net cash from financing operations | -26.95%667.17M | 1,867.94%660.09M | 14,815.14%913.25M | -47.62%33.54M | -84.71%6.12M | 159.16%64.04M | 127.99%40.05M | -129.56%-108.25M | -146.30%-143.09M | 604.81%366.22M |
| Effect of rate | 326.02%26.91M | -383.02%-8.33M | -71.05%-11.91M | 105.48%2.94M | 83.05%-6.96M | -2,172.07%-53.71M | -4,807.29%-41.07M | -92.52%2.59M | 93.51%-837K | 1,302.06%34.65M |
| Net Cash | -32.87%662.8M | 731.17%954.61M | 2,535.89%987.29M | 87.76%114.85M | 55.53%-40.53M | 135.37%61.17M | 60.63%-91.13M | -778.50%-172.92M | -951.10%-231.46M | 68.95%-19.68M |
| Begining period cash | 108.67%1.82B | 15.64%870.8M | 15.64%870.8M | 1.00%753M | 1.00%753M | -19.35%745.54M | -19.35%745.54M | 1.64%924.46M | 1.64%924.46M | -6.28%909.5M |
| Items Period | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.59M | ---1.27M | ---- |
| Cash at the end | 35.78%2.51B | 108.67%1.82B | 161.68%1.85B | 15.64%870.8M | 15.03%705.51M | 1.00%753M | -11.22%613.33M | -19.35%745.54M | -21.00%690.88M | 1.64%924.46M |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.